Apoptosis is considered to be a way of eliminating unwanted cells without causing major inflammation. Nevertheless, several lines of evidence show that apoptotic cell-derived antigens can be strong immunogens. The rabies virus glycoprotein G-ERA is an apoptotic molecule. We tested the ability of G-ERA to potentiate a B cell response against an exogenous antigen (influenza hemagglutinin, HA). We found that co-expression of G-ERA and HA in apoptotic bodies increased both the primary and memory HA-specific immune responses. The immunopotentiation of G-ERA is apoptosis-mediated but not necrosismediated. Our data indicate that G-ERA-mediated apoptosis might be useful to improve the immunogenicity of live vaccines.
Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis. 
INTRODUCTION
Apoptosis is a key phenomenon in the regulation of cell population size and lifespan, and plays an important role in normal tissue homoeostasis and certain pathological conditions, including cancer [1] . In the past few years, a growing number of intracellular microbes (viruses, bacteria, protozoan parasites) have been shown to inhibit or to promote host cell apoptosis [2] . The mechanisms by which dying cells are recognized by scavenger cells, macrophages and dendritic cells (DC), and how these cells present the apoptotic cell antigens are the subject of intense investigation [3] . Furthermore, the role of apoptosis in the induction or prevention of an immune response is still unclear. Indeed, some groups have demonstrated that the uptake of apoptotic cells by DC results in T cell tolerance [4] [5] [6] . Conversely, other groups have shown that DC that have phagocytosed apoptotic bodies from virus-infected cells can present viral antigens to cytotoxic T cells and induce a cytotoxic response [7, 8] . In other systems, antigens produced by apoptotic cells increase the immunogenicity of the antigen [9, 10] . Apoptotic bodies containing the antigen of interest have been obtained by different means such as enforced expression of Fas, cytochrome C, BAX or caspases [11] [12] [13] [14] .
In the context of an infectious disease, the ultimate aim is to develop cheaper, more effective and more rapidly acting vaccines [15] [16] [17] . Some of these features could be achieved by stimulating the humoral immune response. The aim of this study was to evaluate whether the introduction of a pro-apoptotic molecule into a vaccine enhances the B cell response against a vaccine antigen. We have previously shown that the attenuated rabies virus strain ERA triggers mitochondrial/caspase-dependent programmed cell death in different types of human cell [18] [19] [20] and that G-ERA is the key factor responsible for triggering apoptosis [20, 21] .
Here, we tested whether G-ERA can improve the immunogenicity of a recombinant live vaccine. We tested whether G-ERA potentiates the immunogenicity of a vaccine preparation We provide evidence that G-ERA-driven apoptosis of antigen-presenting cells improves the immunogenicity of a vaccine antigen. This finding could berelevant for inserting proapoptotic polypeptides such as G-ERA into live vaccines or DNA/RNA vaccines.
MATERIALS AND METHODS

Cells and viruses:
The mouse lymphoma cells EL4 (ATCC # TIB-39) were established from a lymphoma in a C57BL6 mouse treated with 9,10-dimethyl-1,2-benzanthracene [22] . Cells were grown in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10 mM Hepes, 100 U/ml penicillin, 100 g/ml streptomycin and 5% fetal bovine serum (FBS).
African green monkey kidney fibroblast CV-1 cells (ATCC # CCL-70) and human osteosarcoma 143B cells (ATCC #CRL-8303) were grown in DMEM medium supplemented with 100 mM Na-Pyruvate, 100 U/ml penicillin, 100 g/ml streptomycin and 5% FBS. All cell lines were cultivated at 37°C in a 5% CO 2 atmosphere and split twice a week. Stocks of recombinant VV (Copenhagen strain) were prepared on CV-1 cells as described by Kieny et al [23] .
Construction of recombinant VV:
Recombinant VV were constructed and isolated as previously described [23, 24] . Transfer plasmids, derived from pTG 186poly [23] were used to insert foreign sequences at the vaccinia TK locus. In the ptg-186-poly vector, the foreign gene was under the control of the P7.5 promoter, which had been inserted into the VV tk gene. Immunostaining. HA and G-ERA are expressed at the cell membrane, therefore they were detected by immunostaining as described by Prehaud et al. [20] . Cells were incubated for 1h 
Detection of cell death: Detection of apoptosis was measured by three different techniques:
a) Morphological changes were assessed by measuring side and forward light scattering (SSC and FSC, respectively) in flow cytometry and used to identify apoptotic EL4 T cells as previously described for Jurkat T cells [20] . b) ) The nuclear morphology of normal and apoptotic cells was assessed by staining with Hoechst 33342 (1 µg/ml) and examination under a Zeiss UV microscope. c) DNA fragmentation was assessed by TUNEL as previously described [26] with minor modifications [18] . Apoptotic cells were analyzed by flow cytometry. Apoptosis was blocked by 100 M Z-VAD.
Alternatively necrosis was measured as followed.. Cells stained with propidium iodide (15 min incubation) were measured by flow cytometry. A positive control of necrosis was obtained by treating EL4 cells with acetone.
Preparation of apoptotic bodies: EL4 cells were infected or co-infected with recombinant
VVs at a multiplicity of infection (MOI) of one to three, which infects more than 90% of cells. In co-infection experiments, the multiplicity of infection was calculated so that the amount of HA antigen was the same as in single infections. At 24h post-infection, cells were harvested and apoptosis, necrosis, levels of infection and levels of the proteins were determined for each vaccine batch. If all these criteria were satisfactory, the cells were spun down at 2000g. The pellet was resuspended in PBS and then frozen at -80°C for several hours before being thawed in a 37°C water bath. The released VV virions were inactivated as described by Loewinger and Katz [27] . Briefly, the vaccine preparations were placed on cell culture Petri dishes and were irradiated with UV-C ( 254nm) for 3h. The absence of Statistical analysis. Differences between groups were analyzed using the Student's T test and the Mann-Whitney test. Differences were considered statistically significant for p<0.05 and p<0.01 respectively.
RESULTS
Vectorized G-ERA induces apoptosis of EL4 cells
To investigate whether the pro-apoptotic property of G-ERA was conserved in VV G-ERA, EL4 cells were infected with VV TG 186, VV HA or VV G-ERA at a multiplicity of infection of 3 and the cells were harvested 24 h later. In these conditions, the levels of infection were identical in all three cases: VV TG186 (95%), VV HA (87%) and VV G-ERA (95%). We used three different analysis methods to compare apoptosis. Firstly, we measured the induction of apoptosis by using flow cytometry analysis to compare side and forward light scattering. Cells undergoing apoptosis were found in the R2 population. We found that 48% of cells infected with VV G-ERA were in the R2 population compared to 8% of those infected with VV TG 186 and 25% of those infected with VV HA (Fig 1A and white bars Fig 1B) .
Secondly, we assessed apoptosis by using TUNEL to monitor nuclear fragmentation. We found that 43% of EL4 cells infected with VV G-ERA were TUNEL-positive (43%), compared to 20% of those infected with VV HA and 7% of those infected with VV TG186 (Fig 1B, hatched bars) . Thirdly, we analyzed cell nucleus fragmentation (typical of a late phase of apoptosis) by Hoechst staining (Fig 2B) . Thus, the pro-apoptotic property of G-ERA is conserved in VV G-ERA, as previously demonstrated in other experimental models [20] .
Our results demonstrate the specificity of this mechanism as HA did not act as a major proapoptotic protein when expressed in the same conditions.
As some poxviruses trigger a major cytopathic effect [28] , These data showed that co-infection triggers the production of apoptotic bodies expressing HA and suggest that G-ERA plays a major role in this production.
Apoptotic bodies expressing HA generated by G-ERA immunopotentiate the influenza
Antibody response
We immunized B6 mice with apoptotic bodies generated as described above. We assessed the Ab responses against HA and against rabies virus 12 days later. (Fig 3B) . Thus, HA expression cannot enhance the Ab response against G-ERA. This indicates that, unlike the apoptotic bodies generated by G-ERA, the apoptotic bodies generated by HA expression (Fig 1B) cannot immunopotentiate an antibody response against an exogenous antigen.
Finally, we focused on the role of apoptotic bodies generated by G-ERA on the influenza memory immune response. Mice were injected with VV G-ERA, VV HA or VV G-ERA & VV HA. Six weeks later, they were immunized with a commercial influenza vaccine. The HA Ab response after the boost was higher (p<0.05) for the mice that first had received VV G-ERA/HA than for those that had received VV HA alone (Fig 3C) . Hence the G-ERAmediated immunopotentiation is long-lived.
Blocking apoptosis reduces the immunopotentiation effect
We then studied whether G-ERA-mediated immunopotentiation was strictly linked to the occurrence of apoptosis. EL4 cells were infected with VV G-ERA and VV HA at a multiplicity of infection of 3 and the cells were treated or not with Z-VAD, a pan-caspase inhibitor. In this system, Z-VAD had no effect on the recombinant VV infectious process as the same percentages of infection were obtained in treated and untreated cultures (data not shown). Similarly, treatment of EL4 cells with Z-VAD did not modify G-ERA or HA expression which remained unchanged with or without treatment (data not shown). In presence of Z-VAD, apoptosis driven by VV G-ERA/HA was drastically reduced (2.9 % in presence of Z-VAD and 58.2 % without, Fig 4) . Seven days after injection of mice with the two types of vaccine preparation, the level of HA Ab was significantly higher (p<0.05) when apoptosis was not blocked than when apoptosis was blocked (Fig 4) . This means that blocking apoptosis reduces G-ERA-mediated immunopotentiation, demonstrating that this property of G-ERA requires a caspase-dependent apoptotic process.
In conclusion, G-ERA-mediated immunopotentiation is linked to the generation of apoptotic bodies co-presenting G-ERA and HA.
DISCUSSION
Our data demonstrate that G-ERA, a pro-apoptotic molecule, can immunopotentiate antibody responses to live vaccines. This effect seems to last over the time as shown by the boost experiment. This immunopotentiation was specifically driven by G-ERA; expression of HA had no effect on the immune response directed against rabies virus. We showed that coexpression of G-ERA and HA was crucial. We provided evidence that apoptosis is a key factor of immunopotentiation because it was decreased by ZVAD. Uptake of apoptotic cells and bodies has been described as a powerful mechanism of immunopotentiation [3] . Thus, we hypothesize that fragmentation of a cell expressing a vaccine antigen by G-ERA generates apoptotic bodies that function as powerful vaccine antigen-presenting structures. Apoptosisdriven immunopotentiation is controlled by several factors, including the nature of the apoptotic stimulus, the nature of cells that engulf apoptotic cells, the microenvironment in which cells are dying and the number of dying cells [3] . Different molecules expressed by the dying cells, phagocytes, macrophages and dendritic cells are involved in uptake of dying cells [29] . The best characterized modification of the plasma membrane of apoptotic cells is the loss of phospholipid asymmetry resulting in the exposure of phosphatidylserine (PS) from the inner face on the outer face of the cell membrane. Exposure of PS provides a sufficient signal to inhibit DC maturation and to modulate adaptive immune responses [30] . Exposure of PS may disable G-ERA immunopotentation because G-ERA-mediated apoptosis exposes PS on the dying cell surface [20] . Conversely, antibodies to blebs or apoptotic bodies have been shown to affect the recognition of apoptotic cells by cells of the innate immune system. This may modulate the uptake of antigen complexes that are packed in the dying cells, thus modifying tolerance to foreign antigens [31] . This finding may help to explain the data gathered by Sasaki et al. [13, 14] who showed that "bland" apoptosis can elicit enhanced immune responses. The rabies virus glycoprotein is the main viral antigen. It induces virusneutralizing antibodies that are the major effectors of the immune response against rabies [32] . Rabies virus G-ERA has been vectorized in VV vectors and shown to be an excellent vaccine: it contributed to the control of rabies in European countries [33] . We can assume that following the injection of our vaccines, antibodies directed against G-ERA act as the immunopotentiative effectors that stimulate a strong B cell response against HA as long as this antigen is properly packed in apoptotic bodies. It would be interesting to test the efficacy of the humoral immune response against HA following injection of VV G-ERA/HA apoptotic bodies into mice already primed with the manufactured rabies vaccine.
G-ERA immunopotentiation was drastically decreased, but not abrogated, after ZVAD treatment. Caspase-independent pathways may account for the remaining immunopotentiation effect. Caspase activation is not required for all types of cell death [34] . Furthermore, caspase activation was recently shown to counteract some deleterious processes associated with cell death in some mammalian systems [35] . Overexpression of Bax or Bak induces cell death without the involvement of caspases [36] [37] [38] , suggesting that factors other than caspases can also mediate apoptosis. Indeed, we have reported that the rabies virus strain ERA induces not only a caspase-dependent apoptosis pathway in the human lymphoblastoid Jurkat T cell line but also a caspase-independent pathway involving the apoptosis inducing factor (AIF) [19] .
Further studies are needed to determine whether AIF-mediated apoptosis plays a role in the immunopotentiation effect. Necrosis, a type of uncontrolled cell death releasing noxious components [39, 40] that is not counteracted by ZVAD treatment, can also trigger a potent immune response [3] . In particular, necrotic cells can passively release the High mobility group box 1 protein (HMGB1) as well as heat shock proteins (HSPs), which are known to be pro-inflammatory molecules [41] [42] [43] . However, the denatured proteins generated by necrosis 
